Search results
Results From The WOW.Com Content Network
allogeneic, referring to allotransplantation or an allograft (from other individual of same species). xenogeneic , referring to xenotransplantation or a xenograft (from other species). References
Autologous stem-cell transplantation is distinguished from allogenic stem cell transplantation where the donor and the recipient of the stem cells are different people. [2] It can be also used as an Assisted reproductive technology to improve the reproductive outcomes. In a first step the bone marrow derived stem cells are mobilized.
Allotransplant (allo-meaning "other" in Greek) is the transplantation of cells, tissues, or organs to a recipient from a genetically non-identical donor of the same species. [1] The transplant is called an allograft, allogeneic transplant, or homograft. Most human tissue and organ transplants are allografts.
In xenogeneic cell therapies, the recipient will receive cells from another species. ... syngeneic, autologous, and allogeneic transplants. ... a non-profit ...
Allogeneic transplants are also performed using umbilical cord blood as the source of stem cells. In general, by transfusing healthy stem cells to the recipient's bloodstream to reform a healthy immune system, allogeneic HSCTs appear to improve chances for cure or long-term remission once the immediate transplant-related complications are resolved.
The autologous tissue (also called autogenous, autogeneic, or autogenic tissue) transplanted by such a procedure is called an autograft or autotransplant. [ 2 ] It is contrasted with allotransplantation (from other individual of the same species), syngeneic transplantation (grafts transplanted between two genetically identical individuals of ...
The first transplant of a non-genetically modified [14] [15] pig's heart, lungs and kidneys into a human was performed in Sonapur, Assam, in India in mid-December 1996, and was announced in January 1997. [14] The recipient was Purno Saikia, a 32-year-old terminally-ill man; he died of multiple infections shortly after the operation.
In autologous cancer immunotherapy, T cells are extracted from the patient, genetically modified and cultured in vitro and returned to the same patient. Comparatively, allogeneic therapies involve cells isolated and expanded from a donor separate from the patient receiving the cells.